ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

WG. Wood Group (john) Plc

148.80
-3.40 (-2.23%)
Last Updated: 15:09:42
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Wood Group (john) Plc LSE:WG. London Ordinary Share GB00B5N0P849 ORD 4 2/7P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.40 -2.23% 148.80 148.50 148.90 155.00 146.90 155.00 1,011,515 15:09:42
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Engineering Services 5.9B 464M 0.6707 2.23 1.03B

WOOD GROUP (JOHN) PLC - Wood Wins Contract for Biotech Facility

23/05/2018 7:00am

PR Newswire (US)


Wood Group (john) (LSE:WG.)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Wood Group (john) Charts.

23 May 2018

Wood wins contracts for Teva Biotech facility in Germany

Wood has been awarded a $US multi-million contract by TEVA Biotech GmbH to provide engineering, procurement, construction management, commissioning and qualification (EPCmQ) for a new biotechnological facility to be built in Ulm, Germany.

The plant will produce pharmaceutical ingredients from cell cultures in a new eight-storey building to be constructed within TEVA’s existing biotechnology production site.

Wood EAAA Capital Projects Group will execute detailed design and procurements services for a lump sum fee, as well as construction management and commissioning/qualification services under a reimbursable contract. Expected completion will be 2020, while tech transfer is planned to begin in 2021.

Prior to this award, Wood completed basic design and an investment cost estimate for the same facility under a previous contract, which was awarded on a competitive basis.

Robin Watson, chief executive of Wood, said:  “This contract reflects TEVA’s trust in our ability to execute projects of this size in Germany and validates our global expertise in the development of active pharmaceutical ingredient facilities. We will draw upon our local knowledge, global resources, and four decades of experience working with the world’s top drug manufacturers to deliver a state-of-the-art facility to TEVA.”

This important contract increases Wood’s share in the pharmaceutical market and enhances the company’s scale and diversity in Europe.

-ends-

Note to Editors:

Wood is a global leader in the delivery of project, engineering and technical services to energy and industrial markets. We operate in more than 60 countries, employing around 55,000 people, with revenues of around $10 billion.  We provide performance-driven solutions throughout the asset life cycle, from concept to decommissioning across a broad range of industrial markets, including the upstream, midstream and downstream oil & gas, power & process, environment and infrastructure, clean energy, mining, nuclear, and general industrial sectors. We strive to be the best technical services company to work with, work for and invest in. www.woodplc.com 

For further information contact:  press.office@woodplc.com

Copyright y 22 PR Newswire

1 Year Wood Group (john) Chart

1 Year Wood Group (john) Chart

1 Month Wood Group (john) Chart

1 Month Wood Group (john) Chart

Your Recent History

Delayed Upgrade Clock